Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria (Q35249630)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria
scientific article

    Statements

    Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria (English)
    Christof Iking-Konert
    Martin Aringer
    Jürgen Wollenhaupt
    Thomas Mosch
    Stefan Tuerk
    Eugen Feist
    29 August 2011
    1986-1990

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit